MCM7 and hepatocellular carcinoma: Importantly, transfection of Hep3B cells with anti-miR-93-5p reduced the expression of the MCM7 gene (Figure 5C), cell viability (Figure 5D), increased the sensitivity to Sorafenib, a multikinase inhibitor used to treat HCC (Figure 5D), and inhibited colony formation (Figure 5E).